Kendra Higgins
Medical · Fullerton, CANPI 1063692366
Payments from drug & device makers
Across 163 payments — averaging $22.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$637
- Incyte Corporation$534
- Johnson & Johnson$461
- Sanofi$323
- Pfizer$315
- Regeneron Healthcare Solutions, Inc.$309
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,45892%
- Education$2848%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $637 |
| Incyte Corporation | 22 | $534 |
| Johnson & Johnson | 12 | $461 |
| Sanofi | 10 | $323 |
| Pfizer | 14 | $315 |
| Regeneron Healthcare Solutions, Inc. | 13 | $309 |
| Novartis | 11 | $221 |
| LEO Pharma Inc. | 8 | $187 |
| Krystal Biotech Inc | 4 | $96 |
| Sanofi-aventis U.S. LLC | 4 | $83 |
| Arcutis Biotherapeutics, Inc. | 4 | $76 |
| Galderma Laboratories, L.p. | 4 | $74 |
| Mayne Pharma Commercial LLC | 3 | $65 |
| Sun Pharmaceutical Industries Inc. | 3 | $64 |
| E.r. Squibb & Sons, L.L.C. | 2 | $49 |
| VYNE Pharmaceuticals Inc. | 2 | $46 |
| UCB, Inc. | 1 | $42 |
| Amgen | 2 | $31 |
| Chiesi USA, Inc. | 1 | $31 |
| Almirall LLC | 1 | $25 |
| Dermira, Inc. | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Biofrontera Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPZELURA$112
How this compares
$3,742 in reported general payments places this provider in the 80th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 44 | $1,300 |
| Ketoconazole | 80 | $903 |
| Clobetasol Propionate | 13 | $556 |
| Clindamycin Phosphate | 11 | $519 |
| Triamcinolone Acetonide | 43 | $241 |
| Cephalexin | 27 | $238 |
| Mupirocin | 19 | $145 |
| Finasteride | 31 | $119 |
Paid to pharmacies, not to this prescriber.
Other medical in Fullerton
- Deirdre MoxleyFullerton$149K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.